2028年までのアジア太平洋地域の放射性医薬品市場予測 – 新型コロナウイルス感染症の影響と地域分析（タイプ別（診断用核医学および治療用核医学）、アプリケーション別（腫瘍学、心臓病学、神経学など）、エンドユーザー別（病院、画像センター、学術機関、医療機関）研究センターなど）

市場紹介

APAC は、中国、日本、インド、オーストラリア、韓国の 5 つの主要国で構成されています。この市場は、アジア太平洋地域の他の国々でも評価されます。予測期間中に日本が市場をリードした。近年、日本は核医学分野への関心を高めています。日本は高齢者人口が最も急速に増加する時代に入った。高齢化人口の増加は医療システムの変革をもたらしました。例えば、世界経済フォーラムによると、現在、日本には70代の人口が23億人います。この国では医療の変革が進んでおり、医療システムの持続可能性にますます圧力をかけています。高齢者人口の増加は、この地域における病気の負担を増大させる原因となっています。政府機関や研究機関は放射性医薬品の製造に関与しています。例えば、放射線医学総合研究所の一部である放射性医薬品開発部は、臨床診断や治療に役立つ放射性医薬品の開発、医薬品の合成に必要な新規放射性核種の開発、標識技術の製造を目指しています。新興国での急成長と個別化治療のための核医学の使用の増加が、APACの放射性医薬品市場の成長を促進する主な要因です。

新型コロナウイルス感染症（COVID-19）の場合、APACは特にインドに大きな影響を及ぼします。この地域の医療現場は引き続き新型コロナウイルス感染症の課題に適応し続けている。一方で、医療専門家はパンデミックに対応しており、他方では、新型コロナウイルスに関連しない処置や入院への混乱を最小限に抑えています。世界中の病院やその他の医療施設は、手術などの予定的処置の延期を余儀なくされています。緊急でない治療のほとんどは延期されています。新型コロナウイルス感染症（COVID-19）のパンデミックは、医療施設への通常の患者の流れの中断から始まり、医療リソースにストレスを与え、圧倒することから始まり、医療施設の利用増加による追加の保護措置や社会的距離の確保の実施に至るなど、さまざまな側面で医療サービスに影響を与えました。遠隔医療と仮想医療。予防的アプローチとして、腫瘍内科の診療所では、外来診療の患者数を減らし、不必要または選択的処置を減らし、患者を入院サービスから退院させるための具体的な措置を実施しました。これは、この地域の放射性医薬品市場の成長に悪影響を及ぼしています。さらに、サプライチェーンの逆張りや需要の減少により、市場関係者もパンデミックの影響を受けています。スペシャルティ・ファーマ部門、特に放射性医薬品は、新型コロナウイルス感染症と放射性医薬品の競争により影響を受けた。パンデミック以前でさえ、核医学のサプライチェーンは、原材料の入手可能性、製造施設の運営、航空輸送の信頼性に依存し、非常に複雑でした。したがって、上記の要因は、この地域の放射性医薬品市場に悪影響を及ぼしています。

市場の概要とダイナミクス

アジア太平洋地域の放射性医薬品市場は、2021 年の 13 億 8,459 万米ドルから 2028 年までに 26 億 6,138 万米ドルに成長すると予想されています。 2021 年から 2028 年までに 9.8% の CAGR で成長すると推定されています。標的アルファ療法 (TAT) は、局所および全身のがん治療に使用される最新の進化する技術です。前臨床研究と臨床試験では、アルファ線放射性核種が標的のがん細胞を殺し、健康な細胞には害を及ぼさないことが証明されています（選択的細胞毒性）。 211At、213Bi、225Ac、および 227Th は、モノクローナル抗体などのターゲティングベクターの標識に使用されるアルファ線放射性同位体です。 α線放射性核種で標識されたモノクローナル抗体は、効果的な放射線免疫療法として登場しつつあります。短距離放射性同位体 (α 粒子) は、血液がん患者の治療に使用されます。アルファ線は、腫瘍毛細管内皮細胞（EC）を標的にして殺すために腫瘍毛細管ネットワークを乱すことにより、血管系やリンパ系内の孤立した癌細胞を殺すだけでなく、腫瘍を退縮させるのにも適しています。二塩化ラジウム 223 アルファ療法は、体内でアルファ線を放出する放射性同位元素がん治療の唯一承認されたコンセプトです。悪性組織に到達した後の放射性元素の崩壊により、隣接する健康な組織に重大な損傷を与えることなく、腫瘍を破壊する放射線が放出されます。アルファ線は非常に局所的であり、最大 2 ～ 10 の細胞層を透過します。周囲の組織の健康な細胞は、放射線による損傷からある程度までそれ自体を回復できます。核イメージングでは寿命の長いガンマ線放射体が使用され、時間の経過とともに腫瘍による結合体の取り込みが増加するにつれて血液の除去が可能になり、コントラストが向上します。核造影剤により、腫瘍や臓器の診断が可能になります。さらに、アルファ放射免疫療法についての意識の高まりと、がん治療で利用できる療法の急増により、核イメージングの需要が高まっています。したがって、がんの治療におけるアルファ放射免疫療法の好ましい使用が、APAC 放射性医薬品市場の成長を促進しています。

主要市場セグメント >

種類の点では、2020 年の APAC 放射性医薬品市場で診断用核医学セグメントが最大のシェアを占めました。アプリケーションの点では、腫瘍学セグメントが 2020 年の APAC 放射性医薬品市場でより大きな市場シェアを占めました。 2020。さらに、2020 年のエンドユーザーベースで、APAC 放射性医薬品市場では病院部門がより大きなシェアを占めました。

リストされている主要な供給源と企業

APAC の放射性医薬品市場に関するこのレポートを作成するために参照されたいくつかの主要な一次および二次情報源は、企業の Web サイト、年次報告書、財務報告書、政府文書、統計データベースなどです。レポートに記載されている主要企業は、Advanced Accelerator Applications です。バイエルAG; Bracco Imaging SpA;カーディナル・ヘルス社;キュリウム; ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.;一般電気;ランテウスメディカルイメージング株式会社;ノルディオン;および NTP RADIOISOTOPES。

購入理由レポート

APAC の放射性医薬品市場の状況を理解し、高い収益を保証できる可能性が最も高い市場セグメントを特定する
APAC の放射性医薬品市場の刻々と変化する競争環境を理解することで、競争に先んじる
最も売上が見込める市場セグメントを特定することで、APAC 放射性医薬品市場での M&A やパートナーシップ取引を効率的に計画
さまざまなセグメントの市場パフォーマンスの知覚的かつ包括的な分析から、知識に基づいたビジネス上の意思決定を行うのに役立ちますAPAC 放射性医薬品市場の形成
APAC 地域における 2021 年から 2028 年までのさまざまなセグメント別の市場収益予測を取得します。

アジア太平洋地域の放射性医薬品市場セグメンテーション

アジア太平洋地域の放射性医薬品市場 -タイプ別

核診断医学
- SPECT
- PET
治療用核医学
- アルファ放射体
- ベータ放射体
- 近接照射療法同位体

< p>アジア太平洋地域の放射性医薬品市場 - 用途別

腫瘍学
心臓病学
神経学
その他

アジア太平洋地域の放射性医薬品市場 - >エンドユーザー別

病院
画像センター
学術および研究センター ;
その他

アジア太平洋地域の放射性医薬品市場 - 国別

アジア太平洋の放射性医薬品市場 - 会社概要

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Radiopharmaceuticals Market – By Type

1.3.2 APAC Radiopharmaceuticals Market – By Application

1.3.3 APAC Radiopharmaceuticals Market – By End User

1.3.4 APAC Radiopharmaceuticals Market– By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Radiopharmaceuticals Market– Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Radiopharmaceuticals Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Use of Alpha Radio Immunotherapy for Cancer Treatment

5.1.2 Escalating Advancements in Nuclear Imaging Techniques

5.2 Market Restraints

5.2.1 Presence of Alternatives

5.3 Market Opportunities

5.3.1 Soaring Growth in Emerging Countries

5.4 Future Trends

5.4.1 Rising Use of Nuclear Medicines for Personalized Treatment

5.5 Impact Analysis

6. Radiopharmaceuticals Market– APAC Analysis

6.1 APAC Radiopharmaceuticals Market Revenue Forecast and Analysis

7. APAC Radiopharmaceuticals Market Analysis – By Type

7.1 Overview

7.2 APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Nuclear Medicine

7.3.1 Overview

7.3.2 Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 SPECT

7.3.3.1 Overview

7.3.3.2 SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 PET

7.3.4.1 Overview

7.3.4.2 PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapeutic Nuclear Medicine

7.4.1 Overview

7.4.2 Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Alpha Emitters

7.4.3.1 Overview

7.4.3.2 Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Beta Emitters

7.4.4.1 Overview

7.4.4.2 Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Brachytherapy Isotopes

7.4.5.1 Overview

7.4.5.2 Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Radiopharmaceuticals Market Analysis – By Application

8.1 Overview

8.2 APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

8.3 Oncology

8.3.1 Overview

8.3.2 Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiology

8.4.1 Overview

8.4.2 Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurology

8.5.1 Overview

8.5.2 Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. APAC Radiopharmaceuticals Market Analysis – By End User

9.1 Overview

9.2 APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028, (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Imaging Centres

9.4.1 Overview

9.4.2 Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Centers

9.5.1 Overview

9.5.2 Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. APAC Radiopharmaceuticals Market – Country Analysis

10.1 APAC: Radiopharmaceuticals Market

10.1.1 Overview

10.1.2 APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

10.1.2.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 China: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 China: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.2.2 China: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.1.3 China: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 China: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Japan: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Japan: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.2.2 Japan: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.2.3 Japan: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Japan: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.3 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 India: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 India: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.2.2 India: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.3.3 India: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 India: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.4 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.1 Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.4.2 Australia: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.4.2.1 Australia: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.2.2 Australia: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.4.3 Australia: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.4.4 Australia: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.5 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.1 South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.5.2 South Korea: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.5.2.1 South Korea: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.2.2 South Korea: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.5.3 South Korea: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.5.4 South Korea: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

10.1.2.6 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.1 Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.6.2 Rest of APAC: Radiopharmaceuticals Market, By Type, 2019–2028 (USD Million)

10.1.2.6.2.1 Rest of APAC: Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.2.2 Rest of APAC: Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine, 2019–2028 (USD Million)

10.1.2.6.3 Rest of APAC: Radiopharmaceuticals Market, by Application, 2019–2028 (USD Million)

10.1.2.6.4 Rest of APAC: Radiopharmaceuticals Market, by End User, 2019–2028 (USD Million)

11. Impact Of COVID-19 Pandemic on APAC Radiopharmaceuticals Market

11.1 APAC: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Cardinal Health Inc

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Curium

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GENERAL ELECTRIC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Lantheus Medical Imaging, Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Bracco Imaging S.p.A

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Nordion

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 NTP RADIOISOTOPES

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Advanced Accelerator Applications

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Table 2. China: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. China Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 4. China Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 5. China: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 6. China: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan: Radiopharmaceuticals Market, By Type– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 10. Japan: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 11. Japan: Radiopharmaceuticals Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 12. India: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 13. India Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 14. India Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 15. India: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. India: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 18. Australia Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 19. Australia Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 20. Australia: Radiopharmaceuticals Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 21. Australia: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22. South Korea: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 23. South Korea Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 24. South Korea Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 25. South Korea: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 26. South Korea: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 27. Rest of APAC: Radiopharmaceuticals Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Rest of APAC Radiopharmaceuticals Market, by Diagnostic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 29. Rest of APAC Radiopharmaceuticals Market, by Therapeutic Nuclear Medicine – Revenue and Forecast to 2028 (USD Million)

Table 30. Rest of APAC: Radiopharmaceuticals Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 31. Rest of APAC: Radiopharmaceuticals Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Radiopharmaceuticals Market Segmentation

Figure 2. APAC Radiopharmaceuticals Market Segmentation, By Country

Figure 3. APAC Radiopharmaceuticals Market Overview

Figure 4. Diagnostic Nuclear Medicine Segment Held the Largest Share of the Market in 2021

Figure 5. India to Show Significant Growth During Forecast Period

Figure 6. APAC PEST Analysis

Figure 7. APAC Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints

Figure 8. APAC Radiopharmaceuticals Market– Revenue Forecast and Analysis

Figure 9. APAC Radiopharmaceuticals Market Revenue Share, by Type (2021 and 2028)

Figure 10. APAC Diagnostic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. APAC SPECT: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. APAC PET: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. APAC Therapeutic Nuclear Medicine: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. APAC Alpha Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. APAC Beta Emitters: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. APAC Brachytherapy Isotopes: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. APAC Radiopharmaceuticals Market Revenue Share, by Application (2021 and 2028)

Figure 18. APAC Oncology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Cardiology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. APAC Neurology: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. APAC Radiopharmaceuticals Market Share, by End User, 2021 and 2028 (%)

Figure 23. APAC Hospitals: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24. APAC Imaging Centres: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. APAC Academic and Research Centers: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. APAC Others: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. APAC: Radiopharmaceuticals Market, by Key Country – Revenue (2021) (USD Million)

Figure 28. APAC: Radiopharmaceuticals Market, by Country, 2021 & 2028 (%)

Figure 29. China: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Japan: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. India: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Australia: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. South Korea: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of APAC: Radiopharmaceuticals Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Impact of COVID-19 Pandemic in APAC Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC radiopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC radiopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the radiopharmaceuticals market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample